Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XENE compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name
XENE
Xenon Pharmaceuticals Inc.
Change
Mkt cap
Revenue
Revenue
DFTX
Definium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
XENE
Xenon Pharmaceuticals Inc.
vs
DFTX
Definium Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
XENE: latest quarter is a loss; flow not drawable. DFTX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only XENE
2
NBIX
Neurocrine Biosciences
supplier
BHC
Bausch Health
supplier
Shared
0
No disclosed counterparties: DFTX.
Only DFTX
0
None
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
XENE, solid
DFTX, dashed
XENE
Xenon Pharmaceuticals Inc.
Change
37.91
▲
+1.34%
Mkt cap
$3.6B
Revenue
$8M
Q1 FY25
DFTX
Definium Therapeutics, Inc.
Change
34.30
▼
−5.58%
Regular session
Sep 2 '83
Mkt cap
$4.9B
Revenue
—
vs
Compare
Regular session
Sep 2 '83
XENE
Xenon Pharmaceuticals Inc.
vs
DFTX
Definium Therapeutics, Inc.
37.91
▲
+1.34%
Price
34.30
▼
−5.58%
$3.6B
Mkt cap
$4.9B
Q1 FY25
$8M
Revenue
—
Change
Change
XENE
37.91
▲
+1.34%
vs
DFTX
34.30
▼
−5.58%
Regular session
Sep 2 '83